# Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 201335 NA in Healthy Male Subjects

> **NCT02182362** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 39 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 201335 NA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02182362
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-02
- **Final completion:** —
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2014-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02182362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02182362, "Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 201335 NA in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02182362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*